Stephen Bustin

Professor of Molecular Medicine

Anglia Ruskin University

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Microbiology Microbiology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Stephen Bustin is a faculty member in the Department of Molecular Medicine at Anglia Ruskin University, UK. His research areas include molecular diagnostics, quantitative polymerase chain reaction (qPCR) standards, and the analysis of novel avian viruses. He has contributed significantly to the understanding of qPCR methodologies and their applications in various biomedical contexts, including cancer research and infectious diseases.

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (4)

Sean Young

Assistant Professor

UNITED STATES

View details

Dong-Hun Lee

Assistant professor

University of Connecticut

UNITED STATES

View details

Sun-hak Lee

Research Professor

Konkuk University

SOUTH KOREA

View details

Nham Tran

University of Sydney

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Stephen Bustin

Research Interests

Explore related searches

Contact this professor

About

Articles (21)

Discovery, phylogenetic, and comparative genomic analysis of novel avian gammacoronaviruses identified in feral pigeons ( Columba livia domestica )

When Two-Fold Is Not Enough: Quantifying Uncertainty in Low-Copy qPCR

Fragile methods, fractured trust: rethinking scientific responsibility.

MIQE 2.0: Revision of the Minimum Information for Publication of Quantitative Real-Time PCR Experiments Guidelines

MIQE 2.0 and the Urgent Need to Rethink qPCR Standards

Development of a phenotypic screening assay to measure activation of cancer-associated fibroblasts.

RT-qPCR Testing and Performance Metrics in the COVID-19 Era

Improving the quality of quantitative polymerase chain reaction experiments: 15 years of MIQE

FlashPCR: Revolutionising qPCR by Accelerating Amplification through Low ∆T Protocols

Inhibition of phosphodiesterases 1 and 4 prevents myofibroblast transformation in Peyronie's disease

Temporal gene signature of myofibroblast transformation in Peyronie's disease: first insights into the molecular mechanisms of irreversibility.

Advances in Molecular Medicine: Unravelling Disease Complexity and Pioneering Precision Healthcare

Molecular Pathology, Diagnostics and Therapeutics: A Story of Success in 2022

Maximising the Use of Scarce qPCR Master Mixes

RT-qPCR Detection of SARS-CoV-2: No Need for a Dedicated Reverse Transcription Step

Digital PCR can augment the interpretation of RT-qPCR Cq values for SARS-CoV-2 diagnostics

Variability in RT-qPCR assay parameters indicates unreliable SARS-CoV-2 RNA quantification for wastewater surveillance

RT-qPCR Diagnostics: The “Drosten” SARS-CoV-2 Assay Paradigm

COVID-19 and Diagnostic Testing for SARS-CoV-2 by RT-qPCR—Facts and Fallacies

Inherent Bias of SARS-CoV-2 RNA Quantification for Wastewater Surveillance Due to Variable RT-qPCR Assay Parameters

RT-qPCR Testing of SARS-CoV-2: A Primer

Collaborators (4)

Sean Young

Dong-Hun Lee

Sun-hak Lee

Nham Tran

Make your next move.